The current price of AVIR is USD — it hasn't changed in the past 24 hours. Watch Atea Pharmaceuticals, Inc. stock price performance more closely on the. AVIR Company Profile Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes antiviral therapeutics. Based on 1 Wall Street analysts offering 12 month price targets for Atea Pharmaceuticals in the last 3 months. The average price target is $ with a high. Research Atea Pharmaceuticals' (Nasdaq:AVIR) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance. Discover historical prices for AVIR stock on Yahoo Finance. View daily, weekly or monthly format back to when Atea Pharmaceuticals, Inc. stock was issued.
Track Atea Pharmaceuticals Inc (AVIR) Stock Price, Quote, latest community messages, chart, news and other stock related information. Atea is a clinical-stage biopharmaceutical company working to address unmet medical needs through novel antiviral treatment. Atea Pharmaceuticals, Inc. Atea Pharmaceuticals Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - Atea Pharmaceuticals Presents Positive Initial Phase 2 Data for Bemnifosbuvir and Ruzasvir Combination for Treatment of Hepatitis C Virus at EASL Congress Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Atea is a clinical-stage biopharmaceutical company working to address unmet medical needs through novel antiviral treatment. Atea Pharmaceuticals stock price target cut to $16 from $61 at J.P. Morgan. Oct. 20, at a.m. ET by Tomi Kilgore. (NASDAQ: AVIR) Atea Pharmaceuticals currently has 84,, outstanding shares. With Atea Pharmaceuticals stock trading at $ per share, the total value of. Atea Pharmaceuticals Inc ; Previous Close: ; Open: ; Volume: 85, ; 3 Month Average Trading Volume: ; Shares Out (Mil): Atea Pharmaceuticals Inc ; Previous Close: ; Open: ; Volume: 85, ; 3 Month Average Trading Volume: ; Shares Out (Mil): Atea Pharmaceuticals Inc. ; Prev. Close. ; Low. ; 52wk Low. ; Market Cap. m ; Total Shares. m.
Atea Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering, developing, and commercializing antiviral. Atea is a clinical stage biopharmaceutical company working to address unmet medical needs with innovative oral antiviral therapies. See the latest Atea Pharmaceuticals Inc Ordinary Shares stock price (AVIR:XNAS), related news, valuation, dividends and more to help you make your investing. On Monday 08/05/ the closing price of the Atea Pharmaceuticals Inc Registered Shs share was $ on BTT. Compared to the opening price on Monday 08/05/ Discover real-time Atea Pharmaceuticals, Inc. Common Stock (AVIR) stock prices, quotes, historical data, news, and Insights for informed trading and. View the latest Atea Pharmaceuticals Inc. (AVIR) stock price, news, historical charts, analyst ratings and financial information from WSJ. Atea Pharmaceuticals Inc AVIR:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date02/29/24 · 52 Week Low Stock analysis for Atea Pharmaceuticals Inc (AVIR:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company. View the AVIR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Atea Pharmaceuticals.
AVIR - Atea Pharmaceuticals, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS). Today's High; $ Today's Low; $ 52 Week High; $ 52 Week Low; $ Data Provided by Refinitiv. Minimum 15 minutes delayed. How is Atea Pharmaceuticals' stock traded? The Company's common stock is listed on the NASDAQ Global Market under the symbol “AVIR”. Stock analysis for Atea Pharmaceuticals Inc (AVIR:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company. Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product.
Buy Atea Pharmaceuticals Inc Shares from India at $ (0 Commission) today. Start investing in Atea Pharmaceuticals Inc stocks from India now with. Atea Pharmaceuticals Inc. (AVIR) Stock Performance ; BSE Sensex. , , , ; S&P Small-Cap · , , , AVIR Stock Performance ; Previous close, ; Day range, - ; Year range, 2 - 4 ; Market cap, ,, ; Primary exchange, NASDAQ. Atea Pharmaceuticals Stock (NASDAQ: AVIR) stock price, news, charts, stock research, profile. Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to.
This High Quality stock is Trading at Fair Value!